Chimeric Therapeutics (ASX:CHM) – portfolio of cancer therapies
22 Mar 2023 – Chimeric Therapeutics Limited (ASX:CHM) CEO and Managing Director Jennifer Chow provides an update on the company’s trials.
Chimeric Therapeutics (ASX:CHM) – portfolio of cancer therapies Read More »